Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors.
about
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsImpact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma.Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells.Cell death signaling and anticancer therapyTargeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.Inhibition of autophagy overcomes glucocorticoid resistance in lymphoid malignant cells.Distal substitutions drive divergent DNA specificity among paralogous transcription factors through subdivision of conformational space.Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesInterleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cellsAntibody-based therapy of leukaemia.Pomalidomide therapy for myeloma.Thalidomide: an old drug with new action.Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells.Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements.
P2860
Q28078896-1142DA38-26F6-4BE9-8704-FDF44CEBEAE1Q33828783-63EBCB6D-580C-4F5F-A9B0-DCB6D356F132Q34200686-307C32F5-D2A2-4A04-9A4D-4E8AAFAE5B93Q34374071-92D15745-94D3-4D8F-A20E-44B1E7FBB3C7Q35528996-05E0F9A7-0F0D-496C-9697-44A4B6CF8587Q35972102-35196E42-3074-48BA-9A16-880EE62A99E3Q36172671-C1939473-DF83-4E56-8A3D-E828FFCDF43FQ36213209-A33A78DC-D0A2-47C9-81EB-0B185208F626Q36483218-96490CC4-586A-45DB-B30C-EB9B679FD617Q36589122-012FBEE7-7A54-498B-84D0-EC4173E4418EQ36602853-F70B67CD-73BB-40DC-AB91-7D75BB7F6C53Q37161467-D71E5EFC-D8D0-4AA1-96C5-020937B68C7FQ37605247-4889432B-69F5-46ED-8F19-E4B7FA9A8A78Q37854067-01759F2C-AFF7-4AD7-9544-3460A25F1F57Q37974744-7FEADA1A-8FD3-4C1E-B4D4-4C381796CE13Q39435452-B6497EEA-BBDC-4298-85AB-9AE5FBD32224Q39492090-D93DA7CE-4CD4-4457-88BB-261E4668F5D4Q39918274-7F55816C-9CD4-47E8-B086-7A25B9389735Q41964836-BF5261F5-6EE4-42A5-9020-730ED4C8633EQ46319985-0ACA956A-F09B-4229-BD9E-0B642FA25EFAQ55340271-1F2D2A57-4D21-4FC4-981F-58E3FC4AF641
P2860
Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dexamethasone-induced apoptoti ...... tant glucocorticoid receptors.
@en
type
label
Dexamethasone-induced apoptoti ...... tant glucocorticoid receptors.
@en
prefLabel
Dexamethasone-induced apoptoti ...... tant glucocorticoid receptors.
@en
P2860
P1433
P1476
Dexamethasone-induced apoptoti ...... tant glucocorticoid receptors.
@en
P2093
Alan Lichtenstein
Sanjai Sharma
P2860
P304
P356
10.1182/BLOOD-2007-11-124156
P407
P577
2008-05-30T00:00:00Z